Beyond 532 and 1064 nm: The Role of 785 nm Ti:Sapphire Picosecond Lasers as a Complementary Platform in Tattoo and Pigment Treatment.

Picosecond lasers are increasingly used for tattoo removal and selected pigmentary disorders, but treatment outcomes remain dependent on wavelength, pulse duration, spot size, fluence, pigment chemistry, lesion depth, treatment endpoint, and skin phototype. This narrative review evaluates 785 nm treatment as an emerging complementary option alongside established 532 nm and 1064 nm platforms. A reproducible targeted PubMed/MEDLINE search and structured descriptive evidence extraction were used to identify direct clinical 785 nm studies, mechanistic work, comparator studies, and device-specific regulatory documents. The literature demonstrates that wavelength, laser source, pulse duration, and platform architecture are related but non-interchangeable concepts. Direct 785 nm evidence is limited to small prospective studies, pilot studies, retrospective series, and case reports. The most consistent clinical signal concerns selected cool-colored tattoo pigments, while reports in ephelides, benign facial pigmentation, melasma, and brown dermal melanocytosis remain preliminary. Experimental melanosome-disruption data provide mechanistic plausibility but do not define clinical treatment or safety thresholds. Device terminology also requires caution because nominal 785 nm outputs may be described differently across publications and technical documents. Overall, 785 nm should be considered a target-specific adjunct rather than a universal replacement for 532 nm or 1064 nm treatment. Larger comparative studies with standardized parameters, objective outcomes, longer follow-up, and broader representation of darker skin phototypes are required.